Washington Fiddles While China Burns Our Innovators


By Frank Cullen


The Department of Justice recently charged a Chinese spy for attempted espionage.

But his target wasn't a military institution or government agency -- it was General Electric. The spy had hidden confidential files, involving technology worth millions of dollars, in the codes of digital photographs and sent them back to a co-conspirator in China.

This sort of thievery is distressingly common. In total, Beijing steals approximately $600 billion in American intellectual property every year. This staggering -- and ongoing -- theft has helped make China into the world's second-largest economy and America's greatest geopolitical rival.

A better defense against IP theft is desperately needed. But our leaders shouldn't delude themselves -- cracking down on corporate espionage won't be enough to check the rise of China. Policymakers also need to actively stimulate American innovation, by making it easier for companies to safeguard their best ideas and products. Only then can we out-compete China.

All three branches of government have a role to play in these reforms.

Congress can start by passing Senator Thom Tillis's (R-NC) Patent Eligibility Restoration Act once it's reintroduced, which would effectively overrule a series of disastrous court decisions that have made it nearly impossible for U.S. companies to patent breakthroughs in crucial sectors like biotechnology, artificial intelligence, and 5G networks. Restoring patent eligibility in these fields would stimulate more research here in America and help ensure that capital doesn't flow to other more permissive countries, including China.

The executive branch could impose restrictions on when companies can petition the Patent Trial and Appeal Board, an administrative law body that reviews the validity of patents. For over a decade, Big Tech companies, including major Chinese companies like Huawei, Lenovo and ZTE, have challenged smaller rivals' U.S. patents at the PTAB in addition to litigating related patent challenges and patent infringement cases in the courts -- creating double-jeopardy situations where inventors have to defend their intellectual property on two fronts at once.

That's not fair. Double jeopardy inherently makes intellectual property riskier, and thus less valuable, in the eyes of investors -- and thus depresses startup valuations and deters R&D spending. Companies have a right to challenge the validity of patents they have been accused of infringing -- but they should have to choose between PTAB or the courts, rather than trying their luck in both.

The Federal Trade Commission -- an independent agency, to be clear -- could drop its proposed ban on all non-compete agreements. Without non-compete agreements, employees of high-tech companies would be able to defect to competing firms and easily divulge valuable trade secrets -- thereby derailing their previous employer's breakthrough R&D projects.

The Office of the United States Trade Representative could more forcefully crack down on digital piracy. A recent USTR report noted that China is one of the main sources of illegal recordings of theater performances and films. Such theft devastates the U.S. entertainment industry -- and costs the economy up to $71 billion annually.

The courts could also strike a blow against IP theft by issuing injunctions that force infringers to stop using the patented designs and ideas they've stolen -- rather than merely ordering them to pay monetary damages to partially compensate patent owners for the theft.

Lawmakers are working to combat Chinese IP theft. But we shouldn't pretend it's the only threat to American innovation. We also need to modernize our own laws and regulations to help companies protect, and further develop, their most promising ideas.

Frank Cullen is executive director of the Council for Innovation Promotion.



More Resources


05/05/2024
Biden Has a Problem With Centrist Voters
Biden won the 2020 Democratic nomination as a self-described centrist, but has since adopted more liberal policies that could cost him in 2024.

more info


05/05/2024
Close Presidential Race Careens Toward Uncertain End


more info


05/05/2024
It's the Democrats' Turn To Scare America
No one should be surprised it ended up here.

more info


05/05/2024
Is Trump on Track To Blow the Election?


more info


05/05/2024
The Trump Trial, Columbia Anarchy--and Hope for New York


more info


05/05/2024
New Polls Show Kennedy a Growing Threat to Both Parties
By Adam Garrie, The Kennedy Beacon

more info


05/05/2024
'Equity' Grading Is Latest Educational Fad Destined To Fail
Why work extra hard when you won't be able to get an A? Why try to improve when you won't get worse than a C?

more info


05/05/2024
How Student Encampments Can Strengthen U.S.
Instead of defending the right to protest, many centrists are delegitimizing students, despite the value of what they're doing

more info


05/05/2024
Protesters Should Learn What Genocide Is
Universities are obliged to allow free speech. They are also obliged to make sure that students can attend classes free of harassment.

more info


05/05/2024
From Idealism to Irresponsibility


more info


05/05/2024
Venture Capital's Space for Sheep
vcs should invest in companies that create hype cycles, rather than those that simply follow them

more info


05/05/2024
Trump's Terrible, Horrible, No Good, Very Bad 2nd Term
Millions of us are justifiably focused on seeing that Donald Trump is held to account for what he's allegedly done in the past.

more info


05/05/2024
Biden Can't Win in a Fair Election Against Trump
Former President Donald Trump is getting dragged through the courts via the "lawfare" charges manufactured against him - and seemingly millions of liberals and Democrats are ecstatic. Chaos, turmoil and pain such as this can feel exhilarating when it's the other side's ox being gored.

more info


05/05/2024
Kennedy Jr.'s Plan To Make Biden Drop Out
Independent presidential candidate Robert F. Kennedy Jr. says President Joe Biden is the real "spoiler" in the 2024 presidential race, and he has a plan to make Biden drop out.

more info


05/05/2024
The Adults Are Still in Charge at the University of Florida
Higher education isn't daycare. Here are the rules we follow on free speech and public protests.

more info



Custom Search

More Politics Articles:

Related Articles

Americans Can't Afford Insurance — and Obamacare is to Blame


The number of uninsured Americans rose in 2018 for the first time since the Affordable Care Act passed in 2010, according to the Census Bureau.

ICER Discriminates Against People with Rare Diseases


FDA officials approved a record number of rare disease treatments last year. One groundbreaking medicine treats an inherited bone condition that causes intense pain and immobility. Another treats Fabry disease, a genetic condition that can lead to kidney failure or stroke.

Minor Legislation with Massive Implications


U.S. Senator Ron Johnson (R-WI) is promoting the "Prevent Government Shutdown Act of 2019." The goal of the act is to prevent disruptive government shutdowns.

When Humans Don't Procreate


The "hook" of the story intrigued me: "This hasn't happened in all of modern history..." An email from "The Crux" last month blared, "Global population growth to virtually stop by 2100."

Beware of Bills in Sheep's Clothing


There is a bipartisan tradition of naming bills such that no reasonable person would oppose them. For instance, changes to our tax system came with the passage of the Tax Cuts and Jobs Act. Who's against jobs? And how could anyone have voted against the Patient Protection and Affordable Care Act (i.e., "Obamacare")?

Offshore Bans Hurt Working Class Americans


Congressional Democrats just betrayed America's working class.

If You Like Your Health Plan, You Can't Keep It Under a Public Option


Nearly two in three Americans support the creation of a government-sponsored health plan to compete against plans offered by private insurers, according to the most recent survey data from the Kaiser Family Foundation.

Don't Legalize Discrimination Against People With Disabilities


Imagine if the federal government treated disabled Americans as second-class citizens. It's an appalling thought. But it could happen soon -- if some special interest groups get their way.

It's Time to Turn the Prescription Drug Debate on its Head


Politicians typically blame drug companies for soaring pharmacy prices. But insurers, pharmacies, and other middlemen are the real driving force behind rising drug spending.

U.S. Carbon Emissions Are Actually Dropping


Increased natural gas consumption helped bring down U.S. greenhouse gas emissions in 2019, according to a recent report from the U.S. Energy Information Administration.

"Buy American" Executive Order Could Slow Delivery of a Coronavirus Cure


President Trump is considering a "Buy American" executive order requiring government agencies to purchase medicines and medical supplies domestically.

Don't Disrupt the Supply Chain in the Midst of a Pandemic


The Trump administration fears America has lost its ability to mass-produce the medicines and medical supplies needed to fight the coronavirus and other, future pandemics. So it's considering an executive order to bring drug and medical-supply manufacturing back to the United States.

Intellectual Property Makes Sure Drug Makers Deliver


House Democrats Peter DeFazio, Rosa DeLauro, Lloyd Doggett, and Jan Schakowsky want to nullify intellectual property rights on any experimental treatments for COVID-19. They believe their proposals will prevent "price gouging and profiteering" without harming innovation.

Move These Projects Forward and Get America Back to Work


With more than 40 million Americans out of a job due to the coronavirus pandemic, states are scrambling to help the unemployed and laying plans to reopen the economy.

COVID-19 Cost-Effectiveness Research Deepens Racial Disparities


A newly released study by the Institute for Clinical and Economic Review (ICER), a Boston-based nonprofit, attempts to answer a weighty question: How much should it cost to treat the coronavirus?